Karma ↔ Pharmacodynamics

Karma is the classical term for a drug's action in the body -- the output of rasa, guna, virya, vipaka and prabhava -- and corresponds broadly to pharmacodynamics, though classical karma terms mix mechanism, organ, disease and outcome levels in one vocabulary rather than describing a single mechanistic pathway.

IN PLAIN LANGUAGE

Karma in Dravyaguna simply means what a drug does -- kindles digestion, purges, arrests bleeding, calms the mind -- derived by reasoning through its taste, qualities, potency and post-digestive effect. Modern pharmacodynamics answers the same question, usually in terms of receptors, enzymes and specific molecular targets.

Ayurveda offers a rich, clinically organized vocabulary built from centuries of bedside observation, letting a practitioner read a drug's likely use directly off its properties. Modern pharmacology offers mechanistic proof -- receptor binding, enzyme inhibition, trial outcomes -- that can confirm, redirect, or refute a given classical karma claim.

WHEN TO SEEK CARE

Not a symptom-specific topic; care-seeking depends on the condition a drug's karma is being used for, not on the classification concept itself.

🔴 REFER IMMEDIATELY

Not applicable at the concept level -- safety depends on the specific karma/drug being used therapeutically, not the classification concept itself
A condition where an unsupported karma claim is being relied on in place of a treatment with established modern efficacy, especially in a serious or worsening illness

Never do this

Do not treat a drug's membership in a karma category as equivalent to demonstrated modern efficacy -- a karma is a classical hypothesis about action, not proof of it, and several (e.g., pashanabheda's ashmarighna claim, Kanchanara guggulu's thyroid claim) have no supporting evidence.

🟢 SUITABLE FOR ROUTINE / COLLABORATIVE CARE

AYURVEDA SCOPE

Using a drug's well-attested classical karma (e.g., a documented shwasahara or deepana action) within its traditional dose and preparation.

MODERN MEDICINE SCOPE

Establishing or refuting a drug's claimed action through pharmacological and clinical trial evidence, and identifying the actual mechanism where one exists.

COLLABORATIVE SCOPE

Treating a classical karma claim as a testable hypothesis -- checking it against available pharmacological evidence before relying on it for a serious condition, and preferring drugs whose karma is well supported (e.g., kantakari/bharangi as shwasahara) over ones that are not (e.g., pashanabheda as ashmarighna).

Sign in to read the full comparison

The plain-language summary and safety guidance above are free for everyone. The 10-dimension scholarly comparison needs an account.